☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
roche
Roche to Highlight the P-III (OCARINA II) Trial Results of Ocrevus for Treating Progressive and Relapsing Multiple Sclerosis at AA...
April 17, 2024
Roche Reports Data from the P-III Clinical Evaluation of Columvi to Treat R/R Diffuse Large B-cell Lymphoma
April 15, 2024
Roche’s Elecsys pTau217 Assay to Diagnose Alzheimer's Disease Gains the US FDA’s Breakthrough Device Designation
April 11, 2024
Roche’s Ventana HER2 (4B5) Test Receives CE Mark for HER2-Low Metastatic Breast Cancer
April 10, 2024
PharmaShots' Key Highlights of First Quarter 2024
April 1, 2024
Roche Launches navify Digital Solutions for its Use in Laboratories and Point of Care Services at HIMSS 2024
March 12, 2024
Load more...
Back to Home